This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Blood Group Deletion Syndrome
Information about Blood Group Deletion Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Blood Group Deletion Syndrome
Most recent studies have shown that Blood Group Deletion Syndrome shares some biological mechanisms with acanthocytosis, atrophy, cardiomyopathies, chorea, chorea-acanthocytosis-syndrome, dystrophy, granulomatous-disease-chronic, granulomatous-disorder, hematological-disease, huntington-disease, movement-disorders, muscular-atrophy, muscular-dystrophy, muscular-dystrophy-duchenne, myopathy, nervous-system-disorder, neuromuscular-diseases, retinitis-pigmentosa.
Among the many pathways, these few ones have gauged particular interests from scientists studying Blood Group Deletion Syndrome, and have been seen in publications frequently: Aging, Cardiac Conduction, Cation Homeostasis, Cell Aging, Cell Death, Immune Response, Ion Transport, Localization, Muscle Atrophy, Pathogenesis, Programmed Cell Death, Protein Phosphorylation, Respiratory Burst, Segmentation, Translation, Transport
Quite a number of genes have been found to play important roles in Blood Group Deletion Syndrome, such as CHKA, CHKB, CYBB, DMD, DYNLT3, EDN3, HTT, KEL, MAPRE3, OTC, RPGR, SRPX, SYP, VPS13A, XK. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.